Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF IssuersInvescoIBBQ
ETF screener
IBBQ
US46138G5999
Passive ETFEquity

IBBQ ETF · Invesco Nasdaq Biotechnology ETF

The IBBQ Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: NASDAQ Biotechnology Index. The IBBQ ETF provides physical exposure, so by buying it you actually own parts of all the 253 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update 7/2/2026, 1:30 PM UTC
LIVE
CLOSED
This fund is part ofUS Health Care1M perf.+14.70%
Last price
$33.63
1M perf.
+18.65%
1M flows
-€812K
AuM
€66M
TER
0.19%
Rating
Not rated
IBBQ
$33.63

Performance & flows

Segment for quartile rank
April 2, 2026 → July 2, 2026
00%5%10%15%MAYJUNJULMAYJUNJUL
Create a free account to view the flows graph
IBBQ
$33.63
+15.70%
US Health Care
+14.26%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
+18.65%
icon
+15.70%
icon
+57.06%
icon
+70.19%
icon
+35.09%
icon
+3.04%
+3.04%
+18.79%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
Issuer
CUSIP
46138G599
ISIN
US46138G5999
AuM
€66M
icon
TER
0.19%
icon
Replication rating
Not rated
More details
NAV
7/2/2026
$33.63
1D NAV change
+3.09%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
253
Inception date
6/9/2021
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Similar ETFs in your region

BTEC
1M perf.
+18.64%
TER
0.35%
203780
1M perf.
+14.36%
TER
0.3%
00678
1M perf.
+20.35%
TER
1.01%
IBB
1M perf.
+19.28%
TER
0.44%
DOCG
1M perf.
+12.94%
TER
0.49%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
+15.70%
icon
+57.06%
icon
+70.19%
icon
+35.09%
icon
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
87.03%
United Kingdom
2.68%
Netherlands
2.49%
Ireland
1.84%
France
1.50%
Denmark
1.30%
Switzerland
1.19%
Other
1.97%
Sectors
Healthcare
99.98%
Diversification
Total weight of top 15 holdings out of 253
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:
Not rated
1-year trailing difference
As of June 30, 2026
Create a free account to view the replication graph
IBBQ
N/A
Replication quality
Calculated over 12m, as of June 30, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model

Issuer

Invesco
Invesco ID Card
Number of funds
650
Total AuM
€1.03T
Expense ratio range
0.04% - 5.39%
Average expense ratio
0.3497%
Top 5 funds by Invesco
AuM
QQQ
Invesco QQQ ETF€421.53B
QQQM
Invesco NASDAQ 100 ETF€86.08B
RSP
Invesco S&P 500® Equal Weight ETF€84.6B
SPXS
Invesco S&P 500 UCITS ETF€35.56B
SGLD
Invesco Physical Gold ETC€23.1B

Frequently asked questions about IBBQ

What does Invesco Nasdaq Biotechnology ETF, IBBQ, invest in?

IBBQ is a Passive ETF. This ETF provides exposure to US Equities.

Which benchmark or index does IBBQ replicate?

IBBQ tracks the NASDAQ Biotechnology Index - USD, through a full replication replication method.

What is the Total Expense ratio (TER) of IBBQ?

IBBQ carries a total expense ratio (TER) of 0.19%, indicating the annual cost for holding the fund.

When was IBBQ launched?

IBBQ was introduced to the market on June 9, 2021. It trades on United States

Who is the ETF issuer of IBBQ?

Invesco Nasdaq Biotechnology ETF, IBBQ, is provided by Invesco. Learn more about Invesco here.

What is the current assets under management (AUM) of IBBQ?

IBBQ oversees €66M in assets as of July 2, 2026.

How has IBBQ performed lately?

Based on data from July 2, 2026, IBBQ returned 18.65% over the past month, 15.70% over the last three months and 18.79% year-to-date.

What are the latest inflows or outflows for IBBQ?

As of July 2, 2026, IBBQ recorded net flows of -€836K over the last month and -€644K year-to-date.

Does IBBQ distribute dividends?

IBBQ follows a distributing dividend policy, meaning it pays out income to investors. As of July 2, 2026, its 12-month trailing yield was 0.76%.

What are the main country or region exposures of IBBQ?

As of May 31, 2026, IBBQ has significant geographic allocations in USA, United Kingdom and Netherlands.

In which sector or theme does IBBQ invest in?

As of May 31, 2026, IBBQ focuses largely on Healthcare.

How many securities does IBBQ hold and how diversified is it?

As of May 31, 2026, IBBQ holds 253 positions in its portfolio, with 49.31% of assets concentrated in its top 15 holdings.

What are the main positions in IBBQ?

As of May 31, 2026, IBBQ top three holdings include Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc. and Amgen, Inc..

What is the base currency of IBBQ?

The base currency of IBBQ is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight